Free 7-day Trial
All Articles and Columns »

Diamond Hill Capital Comments on Baxter International

October 24, 2012 | About:

Medical supply manufacturer Baxter International, Inc. (BAX) reported solid second quarter results, which included strong volume and pricing in its antibody therapy. In addition, the company raised its dividend 34% and added $2 billion to its share repurchase capacity. Baxter is planning to add more capacity to break blood plasma into its component parts, which suggests the company is optimistic about future demand.

From Diamond Hill Capital's third quarter Select Fund Commentary.


Rating: 3.0/5 (10 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide